Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

Julia Bohlius(University of Bern), Kurt Schmidlin(University of Bern), Corinne Brillant(University Hospital Cologne), Guido Schwarzer(University Medical Center Freiburg), Sven Trelle(University of Bern), Jerome Seidenfeld(American Society of Clinical Oncology), Marcel Zwahlen(University of Bern), Michael Clarke(Trinity College London), Olaf Weingart(University Hospital Cologne), Sabine Kluge(University Hospital Cologne), Margaret Piper(Blue Cross Blue Shield Association), Dirk Rades(University of Lübeck), David P. Steensma(Mayo Clinic in Arizona), Benjamin Djulbegović(University of South Florida), Martin F. Fey(University Hospital of Bern), Isabelle Ray‐Coquard(Centre Léon Bérard), Mitchell Machtay(RTOG Foundation), Volker Moebus(Klinikum Frankfurt Höchst), Gillian Thomas(Sunnybrook Health Science Centre), Michael Untch(Helios Hospital Berlin-Buch), Martin Schumacher(University Medical Center Freiburg), Matthias Egger(University of Bern), Andreas Engert(University Hospital Cologne)
The Lancet
May 1, 2009
Cited by 592

Abstract


Related Papers

No related papers found

Powered by citation graph analysis